The Cost-Effectiveness Analysis of Self-Efficacy-Focused Structured Education Program for Patients With Type 2 Diabetes Mellitus in Mainland China Setting
Bibliographic Data
| ID | 22091443 |
|---|---|
| Authors | Xinjun Jiang (0000-0002-6515-5180, Peking University), Hua Jiang (0000-0001-9347-5782, Peking University), Libo Tao (Peking University, corresponding author), Mingzi Li (0000-0003-0186-8859, Peking University, corresponding author) |
| Year | 2021 |
| Volume | 9 |
| Pages | 767123-767123 |
| Publication date | 2021-12-09 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Publisher | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2021.767123 |
| PMID | 34957020 |
| OpenAlex | W4200043793 |
| Language | EN |
| Citations received | 2 |
| References cited | 27 |
Objective: To assess the long-term (50 years) cost-effectiveness of the self-efficacy-focused structured education program (SSEP) as opposed to routine education among patients with type 2 diabetes mellitus (T2DM) in mainland China from a healthcare service perspective. Methods: A cost-effectiveness analysis method was used. The IQVIA CORE Diabetes Model (version 9.0) was adopted to estimate the outcomes. The baseline cohort characteristics, variations of physiological parameters, costs of intervention and other treatments, and management-related diabetes were derived from a randomized controlled trial. Moreover, the complications costs and utilities were extracted from published sources. Furthermore, the univariate sensitivity analysis and the probabilistic sensitivity analysis were conducted. Results: As compared with the control group, the life expectancy and quality-adjusted life-year in the intervention group were increased. Besides, the intervention group achieved lower cumulative incidences of complications and saved more direct medical costs compared with the control group. The sensitivity analysis revealed that the SSEP had 100% probability to be cost-effective. Conclusion: The SSEP is recognized as a highly cost-effective option for managing patients with T2DM, which are projected to both improve clinical outcomes and reduce costs
China · Cost effectiveness · Cost-effectiveness analysis · Diabetes mellitus · Mainland China · Physical therapy · Randomized controlled trial · Type 2 Diabetes Mellitus · Chronic Disease Management Strategies · Diabetes Management and Education · Health Systems, Economic Evaluations, Quality of Life · Medicine · Nursing · Internal Medicine
| Citations per year | 0.67 |
|---|---|
| Citation span | 2023 - 2024 (2) |
| Highly cited | No |